Shares of Oculus Innovative Sciences Inc. (NASDAQ:OCLS) traded up 9.5% during mid-day trading on Wednesday . The company traded as high as $4.75 and last traded at $4.36, with a volume of 613,487 shares. The stock had previously closed at $3.98.

Separately, Maxim Group reissued a “buy” rating and set a $7.00 price objective on shares of Oculus Innovative Sciences in a research report on Thursday, August 11th.

The firm’s market capitalization is $18.93 million. The stock has a 50 day moving average price of $4.12 and a 200 day moving average price of $4.67.

Oculus Innovative Sciences (NASDAQ:OCLS) last announced its quarterly earnings data on Thursday, July 28th. The company reported ($0.61) earnings per share for the quarter. On average, analysts predict that Oculus Innovative Sciences Inc. will post ($2.04) earnings per share for the current fiscal year.

Oculus Innovative Sciences, Inc is a specialty pharmaceutical company, which focuses on identifying, developing and commercializing therapies to manage the lives of patients with dermatologic diseases or conditions. The Company’s products treat certain topical skin diseases, including acne, atopic dermatitis, scarring, infections, itch, pain and inflammatory responses.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.